Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Hematologic Diseases × Immunotherapy, Adoptive × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 18 Lymphoma, Large B-Cell, Diffuse 14 Lymphoma, B-Cell 14 Lymphoma, Non-Hodgkin 12 Recurrence 11 Multiple Myeloma 10 Burkitt Lymphoma 9 Lymphoma, Mantle-Cell 8 Lymphoma 8 Leukemia, Myeloid, Acute 7 Carcinoma, Hepatocellular 7 Pancreatic Neoplasms 6 Lymphoma, Follicular 6 Leukemia, Lymphocytic, Chronic, B-Cell 6 Neoplasms 5 Leukemia 5 Stomach Neoplasms 4 Leukemia, B-Cell 4 Hematologic Neoplasms 4 Glioma 4 Colorectal Neoplasms 4 Nasopharyngeal Carcinoma 3 Melanoma 3 Esophageal Neoplasms 3 Breast Neoplasms 3 Simpson-Golabi-Behmel syndrome 2 Sarcoma, Synovial 2 Sarcoma, Ewing 2 Rhabdomyosarcoma 2 Ovarian Neoplasms 2

Interventions

Cyclophosphamide 18 Brentuximab Vedotin 18 fludarabine 14 Rituximab 11 Melphalan 10 Lenalidomide 10 Busulfan 10 fludarabine phosphate 9 Mycophenolic Acid 9 Dexamethasone 9 pirtobrutinib 7 Whole-Body Irradiation 7 Tacrolimus 7 Bortezomib 7 dacetuzumab 6 ruxolitinib 5 Imatinib Mesylate 5 Doxorubicin 5 Bone Marrow Transplantation 5 Azacitidine 5 ponatinib 4 Vincristine 4 Prednisone 4 Mesna 4 Granulocyte Colony-Stimulating Factor 4 Etoposide 4 Blood Specimen Collection 4 nilotinib 3 lintuzumab 3 ibrutinib 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04180059 2026-01-26

CTL-DP 01

Nantes University Hospital

Phase 1 Recruiting

Hematologic Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡